JLJian Liang

Jian Liang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jian Liang has a total of 40 co-authors. Here are the top co-authors by number of shared publications:

  • Xin Deng

    Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, Guangxi Zhuang Autonomous Region, PR China

    3 shared publications
  • Xing-Qiu Liang

    Medical College, Guangxi University, Nanning, China

    3 shared publications
  • Chunxian Liang

    Guangxi Medical College, Nanning, 530023, China

    1 shared publication
  • Fa-Sheng Wu

    Ruikang Hospital of Guangxi University of Chinese Medical

    1 shared publication
  • Fei-Guo Lu

    Department of Infectious Diseases, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning 541100, Guangxi Zhuang Autonomous Region, China

    1 shared publication
  • Hui Qin

    Medical College, Guangxi University, Nanning, China

    1 shared publication

Latest Publications

  • Open Access

    Integrated 16S rRNA sequencing and metabolomics analysis to investigate the antidepressant role of Yang-Xin-Jie-Yu decoction on microbe-gut-metabolite in chronic unpredictable mild stress-induced depression rat model

    by Xing-Qiu Liang, Peng-Yu Mai, Hui Qin, Sen Li, Wen-Juan Ou, Jian Liang, Jing Zhong, Ming-Kun Liang

    Objectives: Our goals were to evaluate the antidepressant efficacy of Yang-Xin-Jie-Yu Decoction (YXJYD) in Chronic Unpredictable Mild Stress (CUMS)-induced depression rat model and to investigate the underlying mechanisms.Design: We used CUMS-induced depression rat model to evaluate whether oral administration of YXJYD with different doses (2.1 g/kg, 1.05 g/kg and 0.525 g/kg, respectively) improve the depressive-like symptoms, and then performed UHPLC-Q-TOF-MS to explore the active ingredients of YXJYD. Subsequently, rat’s cecal contents, serum, and urine were collected from the control group, CUMS model group, and YXJYD high-dose (2.1 g/kg) treatment group. The 16S rRNA sequencing was performed on the cecal contents, based on Illumina MiSeq platform, and ANOVA analysis were used to analyze the composition variety and screen differential expression of gut bacteria in the three groups. 1H Nuclear Magnetic Resonance (NMR) analysis was used for analyzing the metabolites obtained from cecal contents, serum, and urine, and KEGG enrichment analysis was used to identify pathways of differential metabolites. An integrated 16S rRNA sequencing and metabolomic data were conducted to characterize the underlying mechanisms of YXJYDResults: The gut microbial communities, and serum, cecal content, urine metabolic compositions were significantly significantly altered in CUMS-induced depressive rats, while YXJYD effectively ameliorated the CUMS-associated gut microbiota dysbiosis, especially of Monoglobus, and alleviated the disturbance of serum, cecal content, urine metabolome and reversed the changes of key depressive and gut microbiota-related metabolites, such as succinic acid, taurine, hippuric acid, melatonin. With an integrated study of the gut microbiota and metabolomes, we identified the pathway of tricarboxylic acid cycle (TCA cycle) and propanoate metabolism as the regulated target of YXJYD on host-microbiome interaction.Conclusion: Our findings further confirmed the imbalance of metabolism and intestinal microbial is closely related to CUMS-induced depression. YXJYD regulates gut microbiome to affect body metabolomes and then produce antidepressant-like effect in CUMS-induced depressive rats while its molecular mechanism possibly be increased Monoglobus abundance in gut microbiota and regulated the TCA cycle pathway and propanoate metabolism in host.


  • Progress of metal nanoclusters in nucleic acid detection

    by Xia Lin, Lianjia Zou, Weisen Lan, Chunxian Liang, Yanchun Yin, Jian Liang, Yuanming Zhou, Jianyi Wang

    Metal nanoclusters (MNCs), including Ag NCs, Cu NCs, and Au NCs, can be used as fluorescent probes for nucleic acid testing. Identification of DNA fragments and trace detection of miRNA (LOD as low as aM) can be achieved.


  • Open Access

    Effect of Traditional Chinese Medicine Injection on Cancer‐Related Fatigue: A Meta‐Analysis Based on Existing Evidence

    by Zhengkai Huang, Qiang Zhang, Yihua Fan, Jiajing Zhou, Mingkun Liang, Xin Deng, Jian Liang

    Background and Objective. Cancer‐related fatigue (CRF) is a common and painful side effect for cancer patients. The treatment of CRF by traditional Chinese medicine injection (TCMJ) is controversial. We conducted a meta‐analysis and systematic review to evaluate the effect of TCMJ on CRF, with a view to providing some guidance for clinical application. Methods. We systematically searched randomized controlled studies reported through March 2020 in PubMed, EMBASE, the Cochrane Central Register of Controlled Trials, Web of Science, China Biomedical Literature Database (CBM), the China National Knowledge Infrastructure (CNKI), Wanfang, and VIP databases. Two investigators independently screened the studies according to the predetermined criteria, extracted data, and evaluated the bias risk of the included studies, using RevMan5.3 software. Results. Twelve studies enrolling 1005 participants were included in this systematic review. We found that TCMJ could improve the clinical efficacy of CRF patients (RR = 1.24, 95% CI: 1.05–1.46, P = 0.01), ameliorate fatigue status (RR = 1.44, 95% CI: 1.27–1.65, P < 0.00001), and improve quality of life (MD = 8.34, 95% CI: 3.31–13.37, P = 0.001), but there was no statistical significance in the fatigue score (MD = −1.10, 95% CI: −2.23–0.04, P = 0.06). Referring to the number of adverse events, the safety of TCMJ was good. Subgroup analysis showed that TCMJ could improve clinical efficacy, fatigue, and quality of life in a short time (≤4 weeks). Among them, tonic TCMJ could improve the clinical efficacy. TCMJ had advantages in improving fatigue of lung cancer and gastric cancer. In addition, life quality of lung cancer patients improved significantly. Conclusion. Current research evidence showed that TCMJ could improve the clinical efficacy, fatigue status, and life quality of patients with CRF. In addition, we found that TCMJ could improve the clinical efficacy of CRF patients in a short period of time. Tonic TCMJ could improve the clinical efficacy, but heat‐clearing TCMJ could not. Life quality and fatigue status of lung cancer patients improved significantly. However, due to the sample size and quality of the included studies, the results of this analysis should be treated with caution. The above conclusions still need to be verified by more large‐sample and high‐quality randomized controlled trials.


  • Open Access

    Metabolomic profiling for identification of metabolites and relevant pathways for taurine in hepatic stellate cells

    by Xin Deng, Xing-Qiu Liang, Fei-Guo Lu, Xiao-Fang Zhao, Lei Fu, Jian Liang

    To develop a reliable and simple method to identify important biological metabolites and relevant pathways for taurine in hepatic stellate cells (HSCs), in order to provide more data for taurine therapy. All the biological samples were analyzed by using high-performance liquid chromatography-time electrospray ionization/quadrupole-time of flight mass spectrometry. Principal component analysis and partial least squares discriminant analysis were used to identify statistically different metabolites for taurine in HSCs, and metabolomic pathway analysis was used to do pathway analysis for taurine in HSCs. The chemical structure of the related metabolites and pathways was identified by comparing the m/z ratio and ion mode with the data obtained from free online databases. A total of 32 significant differential endogenous metabolites were identified, which may be related to the mechanism of action of taurine in HSCs. Among the seven relevant pathways identified, sphingolipid metabolism pathway, glutathione metabolism pathway and thiamine metabolism pathway were found to be the most important metabolic pathways for taurine in HSCs. This study showed that there were distinct changes in biological metabolites of taurine in HSCs and three differential metabolic pathways including sphingolipid pathway, glutathione pathway and thiamine metabolism pathway might be of key importance in mediating the mechanism of action of taurine in HSCs.


  • Treatment of posthepatitic cirrhosis by Fuzheng Huayu Tablet (扶正化瘀片) for reinforcing qi and resolving stasis

    by Xin Deng, Jian Liang, Zhen-Wei Liu, Fa-Sheng Wu, Xuan Li

    To investigate the efficacy and safety of the Fuzheng Huayu Tablet (扶正化瘀片, FZHYT), which is used to reinforce qi and resolve stasis in patients with posthepatitic cirrhosis (PHC).


  • Sharp feature extraction in point clouds

    by J. Cao, S. Wushour, X. Yao, N. Li, J. Liang, X. Liang

    Sharp feature extraction has been playing an important role in point cloud processing. In this study, a novel method for extracting sharp features from point clouds is presented. It is proposed that in a given point cloud, the displacement between each of the points and the weighted average position in the given neighbourhood of that point is calculated, and the point is labelled as the candidate sharp feature point if the displacement is salient. The normal directions of the obtained candidate sharp feature points are estimated by means of local principal component analysis. Tensor voting is performed to refine the normal estimates. The displacement between a point and its locally weighted average position is projected along the estimated normal direction. The points with extreme projection values are defined as the final sharp feature points. The implementation of the proposed method on both synthesised and practical scanned point clouds show that the method is effective and robust for the purpose of sharp feature extraction.


  • Open Access

    Attenuation of portal hypertension by natural taurine in rats with liver cirrhosis

    by Jian Liang, Xin Deng, Zhi-Xiu Lin, Li-Chun Zhao, Xi-Liu Zhang

    Attenuation of portal hypertension by natural taurine in rats with liver cirrhosis